Abstract
A monoclonal antibody was produced to the exterior envelope glycoprotein (gp120) of the human T-cell lymphotropic virus (HTLV)-IIIB isolate of the human immunodeficiency virus (HIV). This antibody binds to gp120 of HTLV-IIIB and lymphadenopathy-associated virus type 1 (LAV-1) and to the surface of HTLV-IIIB- and LAV-1-infected cells, neutralizes infection by cell-free virus, and prevents fusion of virus-infected cells. In contrast, it does not bind, or weakly binds, the envelope of four heterologous HIV isolates and does not neutralize heterologous isolates HTLV-IIIRF and HTLV-IIIMN. The antibody-binding site was mapped to a 24-amino-acid segment, using recombinant and synthetic segments of HTLV-IIIB gp120. This site is within a segment of amino acid variability known to contain the major neutralizing epitopes (S. D. Putney, T. J. Matthews, W. G. Robey, D. L. Lynn, M. Robert-Guroff, W. T. Mueller, A. J. Langlois, J. Ghrayeb, S. R. Petteway, K. J. Weinhold, P. J. Fischinger, F. Wong-Staal, R. C. Gallo, and D. P. Bolognesi, Science 234:1392-1395, 1986). These results localize an epitope of HIV type-specific neutralization and suggest that neutralizing antibodies may be effective in controlling cell-associated, as well as cell-free, virus infection.
MeSH Terms
Amino Acid Sequence
Antibodies, Monoclonal/immunology
Antibodies, Viral/immunology
Antigens, Viral/immunology
Cell Fusion
Epitopes
HIV/immunology
Immunosorbent Techniques
Molecular Sequence Data
Molecular Weight
Neutralization Tests
Peptide Fragments/immunology
Viral Envelope Proteins/immunology
Chemicals
Antibodies, Monoclonal
Antibodies, Viral
Antigens, Viral
Epitopes
Peptide Fragments
Viral Envelope Proteins
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Matsushita S
Second Department of Internal Medicine, Kumamoto University Medical School, Japan.
Robert-Guroff M
Rusche J
Koito A
Hattori T
Hoshino H
Javaherian K
Takatsuki K
Putney S
References (25)
25 references, click to expand
-
Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody.
J Exp Med. 1981 Dec 1;154(6):1957-64
PMID: 6274993
-
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
Science. 1987 Sep 11;237(4820):1351-5
PMID: 3629244
-
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
Science. 1984 May 4;224(4648):497-500
PMID: 6200935
-
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7
PMID: 6096719
-
Complete nucleotide sequence of the AIDS virus, HTLV-III.
Nature. 1985 Jan 24-30;313(6000):277-84
PMID: 2578615
-
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
Science. 1985 May 31;228(4703):1091-4
PMID: 2986290
-
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.
Nature. 1985 Jul 4-10;316(6023):69-72
PMID: 2989706
-
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
Nature. 1985 Jul 4-10;316(6023):72-4
PMID: 2989707
-
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.
Nature. 1986 Apr 10-16;320(6062):535-7
PMID: 3008001
-
Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2672-6
PMID: 2422659
-
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
Cell. 1986 Jun 6;45(5):637-48
PMID: 2423250
-
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.
Science. 1986 Jun 20;232(4757):1548-53
PMID: 3012778
-
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.
Science. 1986 Jul 11;233(4760):209-12
PMID: 3014647
-
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Nature. 1986 Jul 31-Aug 6;322(6078):470-4
PMID: 3016552
-
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
Proc Natl Acad Sci U S A. 1986 Sep;83(18):7023-7
PMID: 3018753
-
Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
J Immunol. 1986 Nov 1;137(9):2937-44
PMID: 2428879
-
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
Nature. 1986 Oct 23-29;323(6090):725-8
PMID: 3095663
-
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.
Science. 1986 Dec 12;234(4782):1392-5
PMID: 2431482
-
Induction of anti-HIV neutralizing antibodies by synthetic peptides.
EMBO J. 1986 Nov;5(11):3065-71
PMID: 3466790
-
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.
Proc Natl Acad Sci U S A. 1986 Dec;83(24):9709-13
PMID: 2432599
-
Mutational analysis of the signal-anchor domain of influenza virus neuraminidase.
Proc Natl Acad Sci U S A. 1987 Jan;84(1):1-5
PMID: 3025850
-
Characterization of three monoclonal antibodies (VAK3-5) that identify p24, core protein of human immunodeficiency virus, and its precursors.
Jpn J Cancer Res. 1987 Mar;78(3):235-41
PMID: 3106279
-
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.
J Virol. 1987 Jun;61(6):2024-8
PMID: 2437327
-
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
Cell. 1987 Sep 11;50(6):975-85
PMID: 2441877
-
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
Science. 1983 May 20;220(4599):868-71
PMID: 6189183